Control of hypercholesterolemia and atherosclerosis using the cholesterol recognition/interaction amino acid sequence of the translocator protein TSPO

Steroids

Volumn 78, Issue 2, 2013, Pages 137-146

  Lecanu, Laurent ^a,b,c   Yao, Zhi Xing ^c   McCourty, Althea ^a,b,c   Sidahmed, El Khansa ^c   Orellana, Maria E ^b   Burnier, Miguel N ^b   Papadopoulos, Vassilios ^a,b,c  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Atheroma; Cholesterol; CRAC domain; Drug development; LDL; TSPO

Indexed keywords

CARRIER PROTEIN; CHOLESTEROL; CREATINE KINASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MARKER;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONSENSUS; CONTROLLED STUDY; DOSE RESPONSE; GUINEA PIG; HEART INJURY; HOMEOSTASIS; HYPERCHOLESTEROLEMIA; MALE; MUSCLE INJURY; NONHUMAN;

AMINO ACID SEQUENCE; ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BODY WEIGHT; CHOLESTEROL; CHOLESTEROL, DIETARY; CREATINE KINASE; GUINEA PIGS; HEPATOCYTES; HUMANS; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LIVER; MALE; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; ORGAN SIZE; OXIDATIVE STRESS; RECEPTORS, GABA;

CAVIA; MUS;

EID: 84871418994     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2012.10.018     Document Type: Article

References (41)

1. C. Jefcoate High-flux mitochondrial cholesterol trafficking, a specialized function of the adrenal cortex J Clin Invest 110 7 2002 881 890
2. V. Papadopoulos, M. Baraldi, T.R. Guilarte, T.B. Knudsen, J.J. Lacapere, and P. Lindemann Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function Trends Pharmacol Sci 27 8 2006 402 409
3. J.J. Lacapere, and V. Papadopoulos Peripheral-type benzodiazepine receptor: structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis Steroids 68 7-8 2003 569 585
4. V. Papadopoulos, A.G. Mukhin, E. Costa, and K.E. Krueger The peripheral-type benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis J Biol Chem 265 7 1990 3772 3779
5. L. Veenman, and M. Gavish The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development Pharmacol Ther 110 3 2006 503 524
6. M.K. Chen, and T.R. Guilarte Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair Pharmacol Ther 118 1 2008 1 17
7. L. Veenman, V. Papadopoulos, and M. Gavish Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response Curr Pharm Des 13 23 2007 2385 2405
8. J.L. Bird, D. Izquierdo-Garcia, J.R. Davies, J.H. Rudd, K.C. Probst, and N. Figg Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis Atherosclerosis 210 2 2010 388 391
9. Y. Fujimura, P.M. Hwang, I.H. Trout, L. Kozloff, M. Imaizumi, and R.B. Innis Increased peripheral benzodiazepine receptors in arterial plaque of patients with atherosclerosis: an autoradiographic study with [(3)H]PK 11195 Atherosclerosis 201 1 2008 108 111
10. O. Gaemperli, J. Shalhoub, D.R. Owen, F. Lamare, S. Johansson, and N. Fouladi Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography Eur Heart J 33 15 2012 1902 1910
11. J. Dimitrova-Shumkovska, L. Veenman, T. Ristoski, S. Leschiner, and M. Gavish Chronic high fat, high cholesterol supplementation decreases 18 kDa translocator protein binding capacity in association with increased oxidative stress in rat liver and aorta Food Chem Toxicol 48 3 2010 910 921
12. H. Li, and V. Papadopoulos Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern Endocrinology 139 12 1998 4991 4997
13. N. Jamin, J.M. Neumann, M.A. Ostuni, T.K. Vu, Z.X. Yao, and S. Murail Characterization of the cholesterol recognition amino acid consensus sequence of the peripheral-type benzodiazepine receptor Mol Endocrinol 19 3 2005 588 594
14. H. Li, Z. Yao, B. Degenhardt, G. Teper, and V. Papadopoulos Cholesterol binding at the cholesterol recognition/interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide Proc Natl Acad Sci USA 98 3 2001 1267 1272
15. R.M. Epand, B.G. Sayer, and R.F. Epand Caveolin scaffolding region and cholesterol-rich domains in membranes J Mol Biol 345 2 2005 339 350
16. R.F. Epand, B.G. Sayer, and R.M. Epand The tryptophan-rich region of HIV gp41 and the promotion of cholesterol-rich domains Biochemistry 44 14 2005 5525 5531
17. N. Vincent, C. Genin, and E. Malvoisin Identification of a conserved domain of the HIV-1 transmembrane protein gp41 which interacts with cholesteryl groups Biochim Biophys Acta 1567 1-2 2002 157 164
18. Y.H. Zheng, A. Plemenitas, C.J. Fielding, and B.M. Peterlin Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions Proc Natl Acad Sci USA 100 14 2003 8460 8465
19. J.M. McKenney, M.H. Davidson, T.A. Jacobson, and J.R. Guyton Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force Am J Cardiol 97 8A 2006 89C 94C
20. P. Ambrosi, J.L. Gayet, and M. Andrejak The best of 2001. Clinical pharmacology Arch Mal Coeur Vaiss 95 Spec. No. 1 5 Spec. 1 2002 33 38
21. H. Bays Statin safety: an overview and assessment of the data-2005 Am J Cardiol 97 8A 2006 6C 26C
22. K. Tziomalos, V.G. Athyros, A. Karagiannis, and D.P. Mikhailidis Management of statin-intolerant high-risk patients Curr Vasc Pharmacol 8 5 2010 632 637
23. R.S. Rosenson Low high-density lipoprotein cholesterol and cardiovascular disease: risk reduction with statin therapy Am Heart J 151 3 2006 556 563
24. J.M. Lee, and R.P. Choudhury Prospects for atherosclerosis regression through increase in high-density lipoprotein and other emerging therapeutic targets Heart 93 5 2007 559 564
25. P.P. Toth High-density lipoprotein as a therapeutic target: clinical evidence and treatment strategies Am J Cardiol 96 9A 2005 50K 58K
26. G. Cao, T.P. Beyer, Y. Zhang, R.J. Schmidt, Y.Q. Chen, and S.L. Cockerham Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure J Lipid Res 52 12 2011 2169 2176
27. S.J. Nicholls, H.B. Brewer, J.J. Kastelein, K.A. Krueger, M.D. Wang, and M. Shao Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial JAMA 306 19 2011 2099 2109
28. G.B. Lim Coronary artery disease: dalcetrapib safely raises HDL-cholesterol level in the phase IIb dal-PLAQUE trial Nat Rev Cardiol 8 11 2011 610
29. C.B. Sherman, S.J. Peterson, and W.H. Frishman Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis Cardiol Rev 18 3 2010 141 147
30. A.J. Mendez The promise of apolipoprotein A-I mimetics Curr Opin Endocrinol Diabetes Obes 17 2 2010 171 176
31. M. Navab, I. Shechter, G.M. Anantharamaiah, S.T. Reddy, B.J. Van Lenten, and A.M. Fogelman Structure and function of HDL mimetics Arterioscler Thromb Vasc Biol 30 2 2010 164 168
32. J.K. Bielicki, H. Zhang, Y. Cortez, Y. Zheng, V. Narayanaswami, and A. Patel A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice J Lipid Res 51 6 2010 1496 1503
33. M. Navab, G.M. Anantharamaiah, S. Hama, D.W. Garber, M. Chaddha, and G. Hough Oral administration of an Apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol Circulation 105 3 2002 290 292
34. X.H. Liu, J. Xiao, Z.C. Mo, K. Yin, J. Jiang, and L.B. Cui Contribution of D4-F to ABCA1 expression and cholesterol efflux in THP-1 macrophage-derived foam cells J Cardiovasc Pharmacol 56 3 2010 309 319
35. X. Song, P. Fischer, X. Chen, C. Burton, and J. Wang An apoA-I mimetic peptide facilitates off-loading cholesterol from HDL to liver cells through scavenger receptor BI Int J Biol Sci 5 7 2009 637 646
36. Y. Ji, N. Wang, R. Ramakrishnan, E. Sehayek, D. Huszar, and J.L. Breslow Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile J Biol Chem 274 47 1999 33398 33402
37. C.D. Jolley, J.M. Dietschy, and S.D. Turley Induction of bile acid synthesis by cholesterol and cholestyramine feeding is unimpaired in mice deficient in apolipoprotein AI Hepatology 32 6 2000 1309 1316
38. W. Insull Jr. Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review South Med J 99 3 2006 257 273
39. A. Dikkers, and U.J. Tietge Biliary cholesterol secretion: more than a simple ABC World J Gastroenterol 16 47 2010 5936 5945
40. P. Lindemann, A. Koch, B. Degenhardt, G. Hause, B. Grimm, and V. Papadopoulos A novel Arabidopsis thaliana protein is a functional peripheral-type benzodiazepine receptor Plant Cell Physiol 45 6 2004 723 733
41. M.S. Leduc, R.S. Hageman, R.A. Verdugo, S.W. Tsaih, K. Walsh, and G.A. Churchill Integration of QTL and bioinformatic tools to identify candidate genes for triglycerides in mice J Lipid Res 52 9 2011 1672 1682